4//SEC Filing
Carle Vanessa 4
Accession 0001855763-24-000011
CIK 0001348362other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 5:37 PM ET
Size
16.2 KB
Accession
0001855763-24-000011
Insider Transaction Report
Form 4
Carle Vanessa
Secretary
Transactions
- Exercise/Conversion
Stock Options
2024-05-14−2,500→ 60,067 totalExercise: $1.15From: 2023-10-26Exp: 2028-10-26→ Common Shares (2,500 underlying) - Exercise/Conversion
common shares
2024-05-14$1.15/sh+2,500$2,875→ 2,567 total
Holdings
- 62,567
Stock Options
Exercise: $2.36From: 2024-04-26Exp: 2029-04-26→ Common Shares (10,000 underlying) - 40,067
Stock Options
Exercise: $2.91From: 2022-08-29Exp: 2027-08-29→ Common Shares (12,500 underlying) - 67
common shares
- 67
Warrants
Exercise: $36.00From: 2019-11-13Exp: 2024-11-13→ Common Shares (67 underlying) - 12,567
Stock Options
Exercise: $3.00From: 2021-04-26Exp: 2026-04-26→ Common Shares (12,500 underlying) - 17,567
Stock Options
Exercise: $3.00From: 2021-06-08Exp: 2026-06-08→ Common Shares (5,000 underlying) - 27,567
Stock Options
Exercise: $3.00From: 2021-09-01Exp: 2026-09-01→ Common Shares (10,000 underlying) - 52,567
Stock Options
Exercise: $1.15From: 2023-10-26Exp: 2028-10-26→ Common Shares (12,500 underlying)
Footnotes (3)
- [F1]Repriced from $5.31 pursuant to shareholder approval received May 9, 2023
- [F2]Repriced from $7.08 pursuant to shareholder approval received May 9, 2023
- [F3]Repriced from $6.23 pursuant to shareholder approval received May 9, 2023
Documents
Issuer
Lexaria Bioscience Corp.
CIK 0001348362
Entity typeother
Related Parties
1- filerCIK 0001855763
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 5:37 PM ET
- Size
- 16.2 KB